Biosimilars
Companies working to replicate original biologic drugs and distribute them globally at lower prices.
−0.26% today·7 stocks
Stocks
By market cap · 7 stocks
- 1
NVSNovartis (ADR)Developer of focused innovative medicines$267.96B−0.07% - 2
PFEPfizerDeveloper of Eliquis, Prevnar and cancer medicines$158.10B+0.04% - 3
GSKGSK (ADR)Developer of Shingrix, Nucala, and Trelegy$102.34B−1.21% - 4
VTRSViatrisGlobal maker of established brands and generics$19.91B0.00% - 5
ALVOAlvotechIntegrated developer and manufacturer of biosimilars$1.99B−2.30% - 6
CHRSCoherus OncologyLOQTORZI-centered immuno-oncology developer$211.7M−2.55% - 7
AEONAEON BiopharmaTherapeutic Botox biosimilar developer$11.2M+0.83%

